Hypertension Management in Elderly Patients

Treatment Threshold and Rationale

The American College of Physicians (ACP) and American Academy of Family Physicians (AAFP) strongly recommend initiating treatment in adults aged 60 years or older when systolic blood pressure is persistently ≥150 mmHg, with this patient clearly exceeding this threshold 1
The American College of Cardiology (ACC) and American Heart Association (AHA) recommend initiating drug therapy at ≥130 mmHg for adults ≥65 years, as virtually all elderly patients have ≥10% 10-year ASCVD risk 2, 3
Multiple international guidelines, including the European Society of Hypertension (ESH) and European Society of Cardiology (ESC), National Institute for Health and Care Excellence (NICE), and Canadian guidelines, recommend treatment initiation at ≥160 mmHg for patients ≥80 years 4

For patients aged 60-79 years, the target blood pressure is <150/90 mmHg based on high-quality evidence from multiple trials 1
For patients ≥80 years who are community-dwelling and ambulatory, the target blood pressure is <150/90 mmHg based on HYVET trial data 4, 1
For robust elderly patients aged 65-79 years, consider a target blood pressure of <130/80 mmHg based on SPRINT trial results, though this is more controversial 2, 3

The American College of Cardiology (ACC) recommends starting with chlorthalidone or indapamide (thiazide-like diuretics) as first-line therapy, as these agents have superior cardiovascular risk reduction data compared to hydrochlorothiazide 1, 5
Chlorthalidone has a longer duration of action and more effective 24-hour blood pressure control 5

Monitor for orthostatic hypotension at every visit, measuring blood pressure in both sitting and standing positions, and check for symptoms of dizziness, falls, or syncope 1, 6, 2
Monitor for electrolyte disturbances if using thiazide diuretics, checking serum potassium, sodium, and creatinine within 2-4 weeks of initiation 1, 6
Schedule follow-up within 2-4 weeks after medication initiation to assess response and adjust therapy as needed 6

Treatment reduces stroke risk by approximately 36% in older adults 7
Mortality benefit has been demonstrated even in frail elderly patients living independently in the community 2, 3
Both HYVET and SPRINT trials were stopped early for benefit in elderly populations 2, 3

Avoid rapid blood pressure reduction, as gradual titration over weeks to months is safer than aggressive acute lowering 1, 2
Consider non-pharmacologic interventions concurrently, including dietary sodium restriction, weight loss if overweight, regular physical activity, and other lifestyle modifications 1